| This article has been cited by |
| 1 | Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD) | |
| Marinella Ruospo,Suetonia C Palmer,Patrizia Natale,Jonathan C Craig,Mariacristina Vecchio,Grahame J Elder,Giovanni FM Strippoli |
| Cochrane Database of Systematic Reviews.2018;2018(8) |
| [DOI] |
|
| 2 | Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis | |
| Chun-Juan Zhai,Xiao-Wei Yang,Jing Sun,Rong Wang |
| International Urology and Nephrology.2015;47(3)527 |
| [DOI] |
|
| 3 | Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis | |
| Lijuan Zhao,An Liu,Guoshuang Xu |
| Renal Failure.2021;43(1)1378 |
| [DOI] |
|
| 4 | Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis | |
| Stefan Vegter,Keith Tolley,Michael S. Keith,Maarten J. Postma |
| Value in Health.2011;14(6)852 |
| [DOI] |
|
| 5 | The effect of lanthanum carbonate on metabolic acidosis in patients with chronic kidney disease stage IV, V and V-D | |
| William Beaubien-Souligny,Sarah Bezzaoucha,Vincent Pichette,Jean-Philippe Lafrance,Robert Bell,Caroline Lamarche,Denis Ouimet,Michel Vallee |
| International Urology and Nephrology.2015;47(7)1165 |
| [DOI] |
|
| 6 | The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis | |
| Steven Habbous,Sebastian Przech,Rey Acedillo,Sisira Sarma,Amit X. Garg,Janet Martin |
| Nephrology Dialysis Transplantation.2016;47(7)gfw312 |
| [DOI] |
|
